2021 Keynote Information

Celebrating its 12th successful year, SCOPE Summit 2021 takes place March 2-4, 2021 as a fully virtual event. During these difficult times of a global pandemic, the work this clinical research community does is more important than ever and requires collaboration and innovation. Over the course of three stimulating days of in-depth discussions in 23 different conferences, 5 plenary keynote sessions, the 5th annual Participant Engagement Awards, the new China Clinical Development Partnering event and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial innovation, planning, management and operations, including: De-Centralized Trials, Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Telemedicine, Data Strategy and Analytics, Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Resource Management, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Artificial Intelligence, Post-Marketing Studies, Observational Research, Accessing and Generating RWD, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, Clinical Biomarkers and Biospecimens, and Central Lab Solutions, and expanded coverage on Medical Device Clinical Trial Operations and Regulations and Clinical Supply. SCOPE attracted more than 2,200 leaders in clinical operations and research in 2020, and we look forward to you and your team joining us in the first ever virtual SCOPE!

TUESDAY, MARCH 2 - THURSDAY, MARCH 4, 2021

THE ACCELERATION OF DRUG DEV DUE TO THE PANDEMIC

FIRESIDE CHAT: Acceleration of Drug Dev Due to the Pandemic -- Lessons Learned, What Were those Accelerants, Strategic Implications

Moderator: Deborah Borfitz, Senior Science Writer, Clinical Research News & Bio-IT World


Ken Getz, MBA, Founder, CISCRP; Deputy Director, Center for the Study of Drug Development, Tufts University School of Medicine


/images/librariesprovider15/agenda/21/speaker-photos/russo_ralph-circular.jpgLeonard Sacks, MD, Acting Deputy Director, Office of Medical Policy, CDER


CASE STUDY: Working Under Pressure COVID-19 Edition: Pfizer’s Vaccine Trial Decision-Making Strategies and Technology-Boosted Operations

Demetris Zambas, Vice President and Global Head, Data Monitoring and Management, Pfizer


Brett Wilson, Senior Director, Cardiovascular TA Lead Data Monitoring and Management, Pfizer


Ralph Russo, Senior Director and Global Head, Clinical Database Management, Pfizer


CREATIVITY AND ENGAGEMENT IN RECRUITMENT AND RETENTION COMMUNICATIONS: SCOPE’S PARTICIPANT ENGAGEMENT AWARDS

SCOPE’s 2020 Participant Engagement Award

SCOPE's 2021 Participant Engagement Awards

CREATIVITY AND ENGAGEMENT IN RECRUITMENT AND RETENTION COMMUNICATIONS

https://www.scopesummit.com/participant-engagement-award


CHAIRPERSON: David Sall, President & CEO, Patient Enrollment Advisors; Co-Creator of the SCOPE Participant Engagement Award


Kelly McKee, Senior Director, Patient Recruitment and Registries, Medidata; Co-Creator of the SCOPE Participant Engagement Award


Phyllis Kaplan, Trial Volunteer and Patient Advocate; Senior Project Manager, Health Communication Services, Center for Information & Study on Clinical Research Participation (CISCRP)


Irfan Khan, MD, CEO, Circuit Clinical - TrialScout


Micah Lieberman, Executive Director, Conferences, Cambridge Healthtech Institute (CHI)


SOCIAL DETERMINANTS OF HEALTH (SDOH) & MOVING TOWARD PLATFORM THINKING TO TRANSFORM PHARMA

Social Determinants of Health (SDoH) and Its Relevance to Clinical Trials

Conrod Kelly, Executive Director, Marketing and Brand Strategy, Organizational Transformation and Growth; Executive Director, Policy, Government Relations, Merck


INTERACTIVE PANEL: Moving Toward Platform Thinking: Creating a More Seamless Front-End and Back-End to Future-Proof and Advance Digital Transformation in Pharma

Moderator: Adama Ibrahim, EMBA, Director, Digital Solutions, Novartis


Hassan Kadhim, MBA, Director, Head of Clinical Trial Business Capabilities, Global Development Operations, Bristol Myers Squibb


Linda King, Global eCOA Capability Lead, Associate Data Management Director, Medical and Development, Data Science, Astellas Pharma Global Development


Craig Lipset, MBA, Former Head, Clinical Innovation, Pfizer; Venture Partner, Boston Millennia Partners (BMP) & FundRx; Advisor, People-Centered Research Foundation (PCRF)


Mohammed Ali, Global Head, Digital Development, Global Clinical Operations, Boehringer Ingelheim